Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_assertion type Assertion NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_head.
- NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_assertion description "[Therefore, TAP expression restores both antigen presentation and immunogenicity in A375 melanoma cells and concomitantly increases IL-12 and IFN-gamma production in tumor antigen-specific CTLs; TAP should be considered as a part of the immunotherapies for MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_provenance.
- NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_assertion evidence source_evidence_literature NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_provenance.
- NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_assertion SIO_000772 18385764 NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_provenance.
- NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_assertion wasDerivedFrom befree-20140225 NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_provenance.
- NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_assertion wasGeneratedBy ECO_0000203 NP509745.RAa5k9fw1blNY2fyoQuNM8lW6uaGyMCvdt6dyLyIsJph0130_provenance.